Kestra Medical Technologies (KMTS) Liabilities and Shareholders Equity (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $358.5 million in Q2 2026.

• On a quarterly basis, Liabilities and Shareholders Equity rose 21.21% year-over-year to $358.5 million in Q2 2026; TTM through Apr 2026 was $1.3 billion, a 209.81% increase from a year earlier, with the FY2026 full-year figure at $358.5 million, up 21.21% from the prior year.
• Liabilities and Shareholders Equity for Q2 2026 stood at $358.5 million, down from $379.3 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for KMTS reached as high as $379.3 million in Q1 2026 and fell as low as $45.9 million in Q2 2024.
• Historically, Liabilities and Shareholders Equity has averaged $242.9 million across 3 years, with a median of $266.3 million in 2025.
• Across the five-year window, Liabilities and Shareholders Equity soared 543.64% in 2025 and rose 21.21% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $45.9 million in 2024, then jumped by 436.9% to $246.7 million in 2025, then soared by 45.3% to $358.5 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $358.5 million in Q2 2026, $379.3 million in Q1 2026, and $246.7 million in Q4 2025.